BR112018002614B1 - Um processo para a preparação do composto n-(3,5-dimetilfenil)-n'-(2-trifluormetilfenil) guanidina - Google Patents

Um processo para a preparação do composto n-(3,5-dimetilfenil)-n'-(2-trifluormetilfenil) guanidina Download PDF

Info

Publication number
BR112018002614B1
BR112018002614B1 BR112018002614-0A BR112018002614A BR112018002614B1 BR 112018002614 B1 BR112018002614 B1 BR 112018002614B1 BR 112018002614 A BR112018002614 A BR 112018002614A BR 112018002614 B1 BR112018002614 B1 BR 112018002614B1
Authority
BR
Brazil
Prior art keywords
compound
formula
fact
solid form
crystalline solid
Prior art date
Application number
BR112018002614-0A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112018002614A2 (https=
Inventor
José AMATO
Original Assignee
Chemo Research, S.L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Research, S.L filed Critical Chemo Research, S.L
Publication of BR112018002614A2 publication Critical patent/BR112018002614A2/pt
Publication of BR112018002614B1 publication Critical patent/BR112018002614B1/pt

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/08—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/02—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of guanidine from cyanamide, calcium cyanamide or dicyandiamides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/06—Purification or separation of guanidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR112018002614-0A 2015-08-11 2016-08-10 Um processo para a preparação do composto n-(3,5-dimetilfenil)-n'-(2-trifluormetilfenil) guanidina BR112018002614B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP15382424.8 2015-08-11
ARP150102582A AR101498A1 (es) 2015-08-11 2015-08-11 Procedimiento para la preparación del compuesto n-(3,5-dimetilfenil)-n-(2-trifluorometilfenil)guanidina y su forma cristalina a
AR20150102582 2015-08-11
EP15382424 2015-08-11
PCT/EP2016/069033 WO2017025560A1 (en) 2015-08-11 2016-08-10 A process for the preparation of the compound n-(3,5-dimethylphenyl)-n'-(2-trifluoromethylphenyl) guanidine

Publications (2)

Publication Number Publication Date
BR112018002614A2 BR112018002614A2 (https=) 2018-10-02
BR112018002614B1 true BR112018002614B1 (pt) 2023-04-11

Family

ID=56799434

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018002614-0A BR112018002614B1 (pt) 2015-08-11 2016-08-10 Um processo para a preparação do composto n-(3,5-dimetilfenil)-n'-(2-trifluormetilfenil) guanidina

Country Status (21)

Country Link
US (1) US10343984B2 (https=)
EP (1) EP3334707B1 (https=)
JP (1) JP6748188B2 (https=)
CN (1) CN107922322B (https=)
AR (1) AR101498A1 (https=)
BR (1) BR112018002614B1 (https=)
CA (1) CA2994781A1 (https=)
CY (1) CY1122481T1 (https=)
DK (1) DK3334707T3 (https=)
ES (1) ES2756580T3 (https=)
HR (1) HRP20192301T1 (https=)
HU (1) HUE046959T2 (https=)
LT (1) LT3334707T (https=)
MX (1) MX383481B (https=)
PL (1) PL3334707T3 (https=)
PT (1) PT3334707T (https=)
RS (1) RS59759B1 (https=)
RU (1) RU2737430C2 (https=)
SI (1) SI3334707T1 (https=)
SM (1) SMT201900747T1 (https=)
WO (1) WO2017025560A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN172842B (https=) * 1990-05-17 1993-12-11 Boots Pharmaceuticals Limited
EP0910358A1 (en) * 1996-05-24 1999-04-28 Neurosearch A/S Phenyl derivatives useful as blockers of chloride channels
WO2010051129A2 (en) * 2008-10-03 2010-05-06 The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of U.S. Army Medical Research And Materiel Command New imidazolidinedione derivatives as antimalarial agents, preparation thereof, and methods of use
CN103917520B (zh) 2011-10-11 2016-08-24 基尔梅斯国立大学 苯基胍衍生物

Also Published As

Publication number Publication date
EP3334707B1 (en) 2019-10-09
RU2018107840A3 (https=) 2019-12-18
CN107922322B (zh) 2023-11-03
US10343984B2 (en) 2019-07-09
CN107922322A (zh) 2018-04-17
HUE046959T2 (hu) 2020-04-28
RU2018107840A (ru) 2019-09-12
HRP20192301T1 (hr) 2020-03-20
LT3334707T (lt) 2020-01-27
DK3334707T3 (da) 2020-01-06
PL3334707T3 (pl) 2020-05-18
PT3334707T (pt) 2020-01-14
SMT201900747T1 (it) 2020-03-13
US20180244608A1 (en) 2018-08-30
HK1256253A1 (en) 2019-09-20
MX383481B (es) 2025-03-14
JP6748188B2 (ja) 2020-08-26
SI3334707T1 (sl) 2020-03-31
ES2756580T3 (es) 2020-04-27
RS59759B1 (sr) 2020-02-28
AR101498A1 (es) 2016-12-21
JP2018525393A (ja) 2018-09-06
CA2994781A1 (en) 2017-02-16
CY1122481T1 (el) 2021-01-27
MX2018001548A (es) 2018-06-22
BR112018002614A2 (https=) 2018-10-02
WO2017025560A1 (en) 2017-02-16
EP3334707A1 (en) 2018-06-20
RU2737430C2 (ru) 2020-11-30

Similar Documents

Publication Publication Date Title
ES2960953T3 (es) Forma de sal de clorhidrato para la inhibición de EZH2
TWI545124B (zh) ６，７－不飽合－７－胺甲醯基嗎啡喃衍生物之結晶及其製造方法
JP5596680B2 (ja) 経口抗がん製剤
KR20100027137A (ko) 카르바모일-사이클로헥산 유도체의 신규한 용매화물 및 결정 형태
TWI772424B (zh) 一種苯并呋喃類衍生物游離鹼的晶型及製備方法
KR102563378B1 (ko) 2-(1-아실옥시-n-펜틸)벤조산 및 염기성 아미노산 또는 아미노구아니딘이 형성하는 염, 이의 제조 방법 및 용도
JP7025555B2 (ja) 一過性受容体電位ａ１イオンチャネルの阻害
JP2025131661A (ja) ２－（５－（４－（２－モルホリノエトキシ）フェニル）ピリジン－２－イル）－ｎ－ベンジルアセトアミドの固体形態
BR112018002614B1 (pt) Um processo para a preparação do composto n-(3,5-dimetilfenil)-n'-(2-trifluormetilfenil) guanidina
JP7848324B2 (ja) Ｒｉｐｋ１阻害剤の結晶形態
JP2026509019A (ja) 抗ウイルスプロドラッグの結晶形成
JP2025509950A (ja) Ｐｉ３ｋ阻害剤の結晶形態及び塩ならびにその製造方法及びその使用方法
CN105753869B (zh) 一种cdk抑制剂和mek抑制剂的共晶及其制备方法
JP6656505B2 (ja) オービットアジン−フマル酸塩、水和物、結晶形及びその調製方法
TW201922690A (zh) 環－amp反應元素結合蛋白的抑制劑
HK1256253B (en) A process for the preparation of the compound n-(3,5-dimethylphenyl)-n'-(2-trifluoromethylphenyl) guanidine
CN113795492A (zh) 无定形pi3k抑制剂和包含其的药物组合物
RU2802964C2 (ru) Твердые формы 2-(5-(4-(2-морфолиноэтокси)фенил)пиридин-2-ил)-n-бензилацетамида
KR830001211B1 (ko) N-(1-메틸-2-피롤리디닐-메틸)-2,3-디메톡시-5-메틸설파모일 벤즈아미드의 제조방법
WO2026037303A1 (zh) 一种萘酰胺类化合物的晶型及其制备方法和用途
BR112019025797A2 (pt) compostos úteis na inibição do fator trefoil 3 humano
JP2025530060A (ja) 高尿酸血症または痛風を治療若しくは予防するための化合物の固体結晶形
CN105732642A (zh) 一种cdk抑制剂和mek抑制剂的共晶及其制备方法
CN118804753A (zh) 治疗实体瘤的泛素特异性处理蛋白酶1(usp1)抑制剂
BR122024009277A2 (pt) Formas cristalinas de um composto de triazolopirimidina

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI N? 10196/2001, QUE MODIFICOU A LEI N? 9279/96, A CONCESS?O DA PATENTE EST? CONDICIONADA ? ANU?NCIA PR?VIA DA ANVISA. CONSIDERANDO A APROVA??O DOS TERMOS DO PARECER N? 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL N? 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVID?NCIAS CAB?VEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO EM FUNCAO DA REVOGACAO DO ART. 229-C DA LEI NO 9.279, DE 1996, POR FORCA DA LEI NO 14.195, DE 2021

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/08/2016, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REFERENTE A RPI 2727 DE 11/04/2023, QUANTO AO ITEM (54) TITULO.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 9A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2845 DE 15-07-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.